Startseite/Aktien/AGEN

AGEN

USD

Agenus Inc. Common Stock

$3.980+0.140 (3.646%)

Echtzeitkurs

Healthcare

Biotechnologie

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$3.840

Hoch

$3.980

Tief

$3.700

Volumen

0.33M

Unternehmensfundamentaldaten

Marktkapitalisierung

126.8M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.46M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $1.38Aktuell $3.980Hoch $7.34

Ähnliche Nachrichten

10. Sept. 2025 · 10:49

Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Agenus with a Buy and maintains $23 price target.

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target

9. Sept. 2025 · 11:43

BusinessWire

France Grants Reimbursed Compassionate Access (AAC) for Agenus' BOT/BAL in Refractory MSS Metastatic Colorectal Cancer

Agenus Inc. (NASDAQ:AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory microsatellite‑stable

$France Grants Reimbursed Compassionate Access (AAC) for Agenus' BOT/BAL in Refractory MSS Metastatic Colorectal Cancer$

28. Aug. 2025 · 18:04

Earnings Call Transcripts

Agenus Inc. (AGEN) Virtual Stakeholder Briefing Call (Transcript)

28. Aug. 2025 · 14:44

PR Newswire

FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone

Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is helping to fill the gap, with...

FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone

28. Aug. 2025 · 10:50

Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Agenus with a Buy and maintains $23 price target.

BusinessWire

26. Aug. 2025 · 13:37

Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight

Webcast details updated from the August 11th release Webcast on Wednesday, August 27, 2025 at 4:00 p.m. EST Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in immuno-oncology, today announced an update to its